Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10014326HBVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS30086512HIVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS20022380HPVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS20049966HPVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS20049934HPVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS44013458HTLV-1ENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS44020347HTLV-1ENSG00000082175.16protein_codingPGRYesNo5241P06401
TCGA Plot Options
Drug Information
GenePGR
DrugBank IDDB00294
Drug NameEtonogestrel
Target IDBE0000557
UniProt IDP06401
Regulation Typeagonist
PubMed IDs10601100; 11041225; 15063480; 11752352
CitationsMacpherson AM, Archer DF, Leslie S, Charnock-Jones DS, Makkink WK, Smith SK: The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium. Hum Reprod. 1999 Dec;14(12):3080-7.@@Charnock-Jones DS, Macpherson AM, Archer DF, Leslie S, Makkink WK, Sharkey AM, Smith SK: The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. Hum Reprod. 2000 Aug;15 Suppl 3:85-95.@@Sitruk-Ware R: Pharmacological profile of progestins. Maturitas. 2004 Apr 15;47(4):277-83.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved; Investigational
Direct ClassificationEstrogens and derivatives
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Pathways
PharmGKBPA164771231
ChEMBLCHEMBL1531